Enteric fever, encompassing typhoid and paratyphoid fever, is a systemic illness primarily caused by Salmonella enterica serotypes Typhi and Paratyphi A, B, and C. While the disease is largely preventable, it remains a significant health burden in many low- to middle-income countries. This article aims to review recent advancements in the diagnosis and management of enteric fever.
Traditional diagnostic methods, including blood culture, have limitations in sensitivity and specificity. Recent developments focus on molecular techniques such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) which offer higher sensitivity and shorter turnaround times. Additionally, serological tests such as the Typhidot and Tubex TF have shown promise in endemic areas.
Antibiotic resistance has been a growing challenge in the treatment of enteric fever. However, new-generation cephalosporins, such as ceftriaxone and cefixime, and fluoroquinolones have shown efficacy. In severe or resistant cases, azithromycin has emerged as a reliable alternative. It is crucial to base the choice of antibiotic on local resistance patterns.
Prevention is paramount in managing enteric fever. The World Health Organization recommends typhoid vaccination in high-risk areas. The newer conjugate vaccine (TCV) has shown superior efficacy and duration of protection. Furthermore, improving water quality, sanitation, and hygiene (WASH) practices can significantly reduce the burden of disease.
While challenges persist, advancements in diagnostic technologies and evolving treatment strategies have improved the management of enteric fever. Emphasizing prevention through vaccination and WASH practices is crucial. As we continue to innovate and adapt, the goal of controlling and potentially eradicating enteric fever becomes an increasingly attainable reality.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation